Cocrystal Pharma (COCP) Times Interest Earned (2010 - 2026)
Cocrystal Pharma (COCP) posted Times Interest Earned of $107.09 for Q1 2026, up 685.59% sequentially from $13.63 in Q4 2025, and up 69.26% YoY from $63.27 in Q1 2025.
Cocrystal Pharma (COCP) Times Interest Earned (2010 - 2026) Analysis & Trends
Cocrystal Pharma has reported Times Interest Earned for 17 years, with the latest figure at $107.09 in Q1 2026.
- Quarterly Times Interest Earned rose 69.26% year-over-year to $107.09 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$17.85 (up 65.54% YoY) and the FY2025 annual result came in at -$13.38, up 40.95% from the prior year.
- Times Interest Earned rose to $107.09 in Q1 2026 per COCP's latest filing, from $13.63 in the prior quarter.
- Over five years, Times Interest Earned peaked at $107.09 in Q1 2026 and troughed at -$939.54 in Q2 2022.
- A 5-year average of -$72.24 and a median of -$6.09 in 2024 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2022 and 2025: Times Interest Earned tumbled 1299.0% in 2022, then soared 415.26% in 2025.
- Over 5 years, Times Interest Earned stood at -$299.68 in 2022, then soared by 108.65% to $25.92 in 2023, then tumbled by 116.68% to -$4.32 in 2024, then jumped by 415.26% to $13.63 in 2025, then jumped by 685.59% to $107.09 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered $107.09, $13.63, and -$8.63 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Cocrystal Pharma | 15.65 Mn | 13.33 Mn | - | 318.40 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.10 |
| Mar 31, 2026 | 107.09 |
| Dec 31, 2025 | 13.63 |
| Sep 30, 2025 | -8.63 |
| Jun 30, 2025 | -7.87 |
| Mar 31, 2025 | 63.27 |
| Dec 31, 2024 | -4.32 |
| Sep 30, 2024 | -12.15 |
| Jun 30, 2024 | -2.56 |
| Mar 31, 2024 | 18.90 |
| Dec 31, 2023 | 25.92 |
| Sep 30, 2023 | 13.88 |
| Jun 30, 2023 | -23.84 |
| Mar 31, 2023 | -91.27 |
| Sep 30, 2022 | -299.68 |
| Jun 30, 2022 | -939.54 |
| Mar 31, 2022 | -8.69 |
| Sep 30, 2021 | -74.58 |
| Jun 30, 2021 | -67.16 |
| Mar 31, 2021 | -40.26 |